Zach Taylor, MBA


Zach is a business development professional with over 25 years of experience in biotech, pharma and medtech industries. He currently serves as Senior Vice President, Corporate Development & Strategy at BioNTech SE where he helps drive strategic transactions and corporate strategy. Zach helped incubate his previous company, Neon Therapeutics, as a consultant to Third Rock Ventures, conducting diligence and helping create the company business plan culminating in a $55 million Series A financing in 2015. Zach was also a key contributor to Neon’s IPO process in 2018 and the eventual sale of the company to BioNTech in 2020. Prior to Neon, Zach held a number of business development roles and strategy roles at companies notably Millennium Pharmaceuticals (acquired by Takeda) and Philips Research in the Netherlands. While at Philips, Zach co-founded and helped spin out Tagworks Pharmaceuticals into an independent company.

Zach holds a BS in engineering physics from Cornell University and earned his MBA from the Kellogg School of Business– Northwestern University.

Curious about what we do? Get in touch!


About    Our Technology   Pipeline    Join us    News    Contact

T +31 85 800 8550

Tagworks Pharmaceuticals BV
Toernooiveld 1
6525 ED  Nijmegen
The Netherlands

Stay updated

© Tagworks Pharmaceuticals, 2024 | Terms of use | Design by Ape to Zebra